Despite overall decline or stabilization, increase seen for young adults in some high-income countries
Risk for cancer, mortality increased for patients with pediatric-onset ulcerative colitis, Crohn disease.
Patients were predicted to achieve their minimum weight at 24 months after ESG.
Risk lasts through 40 years of adulthood for underweight adolescent men.
Patients with irritable bowel disease planning to start immunosuppressive therapy may need to receive a pneumococcal vaccination beforehand.
Real-time risk score predicts incisional hernias following abdominal surgery.
Improvements in symptoms, life impact maintained at 12 months.
The FDA has granted Breakthrough Therapy designation to elafibranor for the treatment of primary biliary cholangitis (PBC) in adults with inadequate response to ursodeoxycholic acid (UDCA).
Raw ground tuna supplied by Jensen Tuna is likely source of outbreak
According to the results of a recent study, an aggressive revaccination strategy involving 3 additional hepatitis B (HBV) vaccine doses is recommended for inflammatory bowel disease (IBD) patients with initial HBV vaccination failure.
Early step-up combo therapy includes tumor necrosis factor-α antagonist plus an antimetabolite.
To determine the effects on colorectal cancer screening response rates, researchers compared various forms of financial incentives with the same monetary value.
The American College of Gastroenterology guidelines highlight the preferred practice recommendations to treat adult patients with ulcerative colitis.
According to the results of a retrospective cohort study, male patients who utilize proton pump inhibitors (PPIs) appear to be at increased risk of developing gynecomastia.
Compared to placebo, treatment with ustekinumab resulted in a significantly greater proportion of adults with moderate to severe UC achieving clinical remission at week 44 (primary endpoint).
Vedolizumab (Entyvio; Takeda), an integrin receptor antagonist, was found to be superior to adalimumab (Humira; AbbVie), a tumor necrosis factor-alpha (TNFα) antagonist, in achieving clinical remission in patients with moderately to severely active ulcerative colitis (UC), according to results from a phase 3b head-to-head trial.
Children from lower-income households are more likely to report recent childhood gastrointestinal and respiratory illnesses but are less likely to miss any school days.
No significant differences in surgical complication risk were seen in early or delayed cholecystectomy for acute cholangitis and acute cholecystitis.
In addition to sociodemographic factors, preterm birth and older age were associated with lower rotavirus vaccine coverage.
Sixty-three more cases of illness in a Salmonella outbreak linked to raw turkey products have been reported since Dec 21, 2018, bringing the total number to 279.